316. Carnitine cycle disorder
4 clinical trials,   10 drugs   (DrugBank: 4 drugs),   2 drug target genes,   9 drug target pathways

Searched query = "Carnitine cycle disorder", "Carnitine palmitoyltransferase I deficiency", "CPT1 deficiency", "Carnitine palmitoyltransferase II deficiency", "CPT2 deficiency", "Carnitine-acylcarnitine translocase deficiency", "CACT deficiency", "Carnitine transporter deficiency", "OCTN-2 deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02517307
(ClinicalTrials.gov)
February 20162/7/2015Fatty Acid Oxidation Defects and Insulin SensitivityRole of Fatty Acid Oxidation Defects in Insulin SensitivityVery Long-chain Acyl-CoA Dehydrogenase Deficiency;Trifunctional Protein Deficiency;Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency;Medium-chain Acyl-CoA Dehydrogenase Deficiency;Normal Volunteers;Carnitine Palmitoyltransferase II Deficiency, MyopathicDrug: Intralipid/Heparin;Drug: Glycerol/Saline;Drug: Hyperinsulinemic euglycemic clampOregon Health and Science UniversityNULLRecruiting18 YearsN/AAll50N/AUnited States
2NCT02226419
(ClinicalTrials.gov)
August 20135/8/2013Fat and Sugar Metabolism During Exercise, With and Without L-carnitine in Patients With Carnitine Transporter DeficiencyFat and Carbohydrate Metabolism During Exercise, With and Without L-carnitine Supplementation in Patients With Carnitine Transporter DeficiencyCarnitine Transporter, Plasma-membrane, Deficiency ofDietary Supplement: Break in L-carnitine treatmentKaren Lindhardt MadsenRigshospitalet, DenmarkCompleted18 YearsN/ABoth14N/ANULL
3NCT00983788
(ClinicalTrials.gov)
October 200923/9/2009Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation DefectsEvaluation of the Effect of Bezafibrate on Muscle Metabolism During Exercise in Patients With CPTII and VLCAD DeficiencyCarnitine Palmitoyltransferase II Deficiency;Very Long Chain Acyl Coa Dehydrogenase DeficiencyDrug: Bezafibrate;Other: PlaceboRigshospitalet, DenmarkInstitut de Myologie, Pitié-Salpêtrière Hospital, FranceCompleted18 Years70 YearsBoth12Phase 2Denmark
4NCT00336167
(ClinicalTrials.gov)
June 20069/6/2006Bezafibrate Trial in CPT2 DeficiencyClinical Trial on the Effect of Bezafibrate in the Muscular Form of Carnitine Palmitoyltransferase 2 DeficiencyCarnitine Palmitoyl Transferase 2 DeficiencyDrug: bezafibrate (drug)Assistance Publique - Hôpitaux de ParisAssociation Française contre les Myopathies (AFM), Paris;Institut National de la Santé Et de la Recherche Médicale, FranceRecruiting18 YearsN/ABoth12Phase 3France